Stay updated with breaking news from Foresite Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize…
AI's use in drug discovery and health care is a rare area where the public is also more optimistic than anxious about AI's potential.
Xaira's CEO, Dr. Marc Tessier-Lavigne, resigned as president of Stanford University last August due to controversy over inaccuracies discovered in his lab's scientific papers.
Plus: Electronic health record company Veradigm’s $140 million AI gamble on startup ScienceIO.
– STRIDE Phase 2 primary endpoint of PASI 75 and key secondary endpoints met at all clinically relevant doses tested; sustained maximal target inhibition safely achieved at top dose –